Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge
Not Applicable
Recruiting
- Conditions
- Breast Carcinoma
- Interventions
- Procedure: Contrast Enhanced Digital MammographyProcedure: Digital Tomosynthesis MammographyDrug: Iodinated Contrast AgentOther: Questionnaire Administration
- First Posted Date
- 2021-09-27
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 66
- Registration Number
- NCT05056844
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Distress Associated With Coronavirus Disease 2019 and Telehealth on Supportive Care Patients With Advanced Cancer
Active, not recruiting
- Conditions
- Locally Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid NeoplasmAdvanced Malignant Solid NeoplasmCOVID-19 InfectionRecurrent Hematologic MalignancyRecurrent Malignant Solid Neoplasm
- Interventions
- Other: Survey Administration
- First Posted Date
- 2021-09-27
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 223
- Registration Number
- NCT05058339
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer
Not Applicable
Active, not recruiting
- Conditions
- Prostate CarcinomaProstate Adenocarcinoma
- Interventions
- Procedure: Magnetic Resonance Imaging
- First Posted Date
- 2021-09-24
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 33
- Registration Number
- NCT05055843
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema
Not Applicable
Active, not recruiting
- Conditions
- Lymphedema
- Interventions
- Other: Cohort II (patients followed intensively for lymphedema)Other: Cohort I (patients receiving annual lymphedema screening
- First Posted Date
- 2021-09-24
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 260
- Registration Number
- NCT05056207
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
Recruiting
- Conditions
- Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
- Interventions
- Other: Questionnaire Administration
- First Posted Date
- 2021-09-23
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT05054413
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases
Phase 4
Completed
- Conditions
- Metastatic Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain
- Interventions
- Radiation: Fludeoxyglucose F-18Procedure: Magnetic Resonance ImagingProcedure: Positron Emission Tomography
- First Posted Date
- 2021-09-23
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT05054998
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630
Phase 1
Suspended
- Conditions
- BladderBladder Cancer
- Interventions
- Drug: UGN-201
- First Posted Date
- 2021-09-23
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT05055050
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
Early Phase 1
Withdrawn
- Conditions
- Brain MetastasesGlioblastomaGliomasCancer
- Interventions
- Drug: F18 FluciclovineOther: Standard of Care
- First Posted Date
- 2021-09-23
- Last Posted Date
- 2023-09-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT05054400
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With Cancer
Active, not recruiting
- Conditions
- Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
- Interventions
- Other: Electronic Health Record ReviewOther: Survey Administration
- First Posted Date
- 2021-09-23
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 110
- Registration Number
- NCT05055011
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
Phase 2
Recruiting
- Conditions
- Metastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8Biochemically Recurrent Prostate CarcinomaStage IVA Prostate Cancer AJCC v8
- Interventions
- Behavioral: Educational InterventionBehavioral: Exercise InterventionDevice: FitBitOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2021-09-23
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT05054296
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath